PI3K delta inhibitors (University of Lyon/Centre National de la Recherche Scientifique/INSERM)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePI3K delta inhibitors (University of Lyon/Centre National de la Recherche Scientifique/INSERM)
Drug Alias NamePI3K delta inhibitors (University of Lyon)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsHypersensitivityNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Lyon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of LyonPulsalysCentre National De La Recherche Scientifique (Cnrs) +[4] 
Active IndicationsN/A
Inactive IndicationsHypersensitivityNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A